Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Causes and clinical significance of prolonged activated partial thromboplastin times in thalassaemia major

McFadyen J, Butler J, Malan E, Tran H

(2014), Ann Hematol, 93(5), 867-8

Prothrombin complex concentrate safely reverses warfarin-related bleeding

Tran H, Chunilal S

(2014), Evid Based Med, 19(2), 75

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)

Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, Gandhi MK, Truman M, Marlton P, Catalano J

(2014), Br J Haematol, 167(2), 243-51

An update of consensus guidelines for warfarin reversal

Tran HA, Chunilal SD, Tran H

(2014), Med J Aust, 200(2), 82

The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa

Htun KT, McFadyen J, Tran HA

(2014), Ann Hematol, 93(10), 1785-6

Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes

Tikellis C, Brown R, Head GA, Cooper ME, Thomas MC

(2014), Am J Physiol Renal Physiol, 306(7), F773-80

Underestimation of myelodysplastic syndrome incidence by cancer registries: results from a population-based data linkage study

McQuilten ZK, Wood EM, Polizzotto MN, Campbell LJ, Wall M, Curtis DJ, Farrugia H, McNeil JJ, Sundararajan V

(2014), Cancer, 120(11), 1686-94

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes

Crack PJ, Zhang M, Morganti-Kossmann MC, Morris AJ, Wojciak JM, Fleming JK, Karve I, Wright D, Sashindranath M, Goldshmit Y, Conquest A, Daglas M, Johnston LA, Medcalf RL, Sabbadini RA, Pébay A

(2014), J Neuroinflammation, 11, 37

Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL

McCormack MP, Shields BJ, Jackson JT, Nasa C, Shi W, Slater NJ, Tremblay CS, Rabbitts TH, Curtis DJ

(2013), Blood, 122(12), 2093-103

Cardiac imaging in FIP1L1-PDGFRA

Jaworski C, Looi JL, Martin J, Bergin P, Hare J, Kaye D, Wei A, Taylor AJ

(2013), J Am Coll Cardiol, 62(14), 1304

Stem cells behind the barrier

Cangkrama M, Ting SB, Darido C

(2013), Int J Mol Sci, 14(7), 13670-86

The regulation of mitochondrial metabolism by the Bcl-2fFamily of pro-survival proteins: new therapeutic opportunities for targeting cancer cells

Wei A, Brown M, Guthridge MA

(2013), J Hematol Thromb Dis, 1(4), 121

Efficacy, safety and survival with ruxolitinib in patients with smyelofibrosis: results of a median 2-year follow-up of COMFORT-I

Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, Catalano JV, Deininger MW, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner EO, Lyons RM, Paquette R, Raza A, Vaddi K, Erickson-Viitanen S, Sun W, Sandor V, Kantarj

(2013), Haematologica, 98(12), 1865-71

An investigation on platelet transport during thrombus formation at micro-scale stenosis

Tovar-Lopez FJ, Rosengarten G, Nasabi M, Sivan V, Khoshmanesh K, Jackson SP, Mitchell A, Nesbitt WS

(2013), PLoS One, 8(10), e74123

ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura

Shortt J, Oh DH, Opat SS

(2013), N Engl J Med, 368(1), 90-2

Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2

Schuliga M, Langenbach S, Xia YC, Qin C, Mok JS, Harris T, Mackay GA, Medcalf RL, Stewart AG

(2013), Am J Respir Cell Mol Biol, 49(5), 751-8

The fusion partner specifies the oncogenic potential of NUP98 fusion proteins

Saw J, Curtis DJ, Hussey DJ, Dobrovic A, Aplan PD, Slape CI

(2013), Leuk Res, 37(12), 1668-73

Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263)

Qiao J, Schoenwaelder SM, Mason KD, Tran H, Davis AK, Kaplan ZS, Jackson SP, Kile BT, Andrews RK, Roberts AW, Gardiner EE

(2013), Blood, 121(8), 1479-81

Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier

Niego B, Medcalf RL

(2013), J Vis Exp, 81, e50934

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC

Mithraprabhu S, Khong T, Jones SS, Spencer A

(2013), Br J Haematol, 162(4), 559-62